You searched for "calcification"

2228 results found

The Irlen Experience

My father used to say that humanity is divided into those that see the world through a moral framework and recognise their place within it, and Tories. When a concerned mother came to the paediatric clinic bearing literature from the...

The International AMD Genomics Consortium study: another success in understanding the complex genetics of AMD

Age-related macular degeneration (AMD) is a neurodegenerative complex disease of the eye and a major cause of blindness and visual impairment among the elderly worldwide. The early stages of the disease are characterised by asymptomatic pigmentary abnormalities and accumulation of...

‘Phaco-plus’ procedures at forefront of modern glaucoma management

Glaucoma and cataract increasingly present as a ‘two-in-one’ surgical opportunity. In the UK, new modelling suggests ~1 million adults aged ≥40 may currently have glaucoma, with a projected rise to ~1.6 million by 2060 as the population ages and demographics...

OSA Insights to Market win praise from members

OSA members praised the breadth of optical market insights provided by the Autumn meeting this week as a broad spectrum of suppliers gathered in London, reinforcing the strength of the trade body.

CALL TO ACTION: Help the Ridley Eye Foundation ‘reach more of the unreachable’ in the Himalayas

On the 29 November 1949, Harold Ridley carried out the first implant of an intraocular lens (IoL). This was the first major breakthrough in the cure of cataract blindness since Jacques Daviel conducted the first extra-capsular extraction 198 years earlier....

International Ocular Inflammation Society (IOIS) Congress September 2023 in a sweltering Berlin

Approaching its 40th year, IOIS remains focused on advancing research and knowledge-sharing around ocular inflammatory diseases.

Thomas Pocklington Trust and Guide Dogs expands student support services to include younger age group

Sight loss charities, Guide Dogs and Thomas Pocklington Trust (TPT) are working together to deliver advice and guidance to blind and partially sighted students, their families and carers and any professionals that support them. The two charities have partnered to...

Contemporary glaucoma therapy: spoilt for choice

The goal of glaucoma management is to prevent visual loss and disease progression in the patient’s lifetime through effective lowering of intraocular pressure (IOP), the primary modifiable risk factor in glaucoma. Sustained and consistent IOP reduction is key to halting...

Dementia and visual impairment: what is the relationship and are we providing the best care?

Carla Maden discusses the implications of living with both dementia and visual impairment, and how general medical junior doctors and ophthalmologists can help to alleviate this burden and improve the quality of life of such patients. Dementia and visual impairment...

Lancet Commission calls for global action on blindness

The Lancet Global Health Commission on Global Eye Health highlights the changing nature of the issues facing eye health professionals worldwide.

A case of late spontaneous subluxation of in-the-bag intraocular implant

An 82-year-old frail lady was referred by her optometrist with a finding of subluxated implant in the right eye. She had uneventful phacoemulcification with in-the-bag intraocular implant 17 years earlier. There is no history of having had pseudoexfoliation (PXF) or...

Licence to save: a UK survey of anti-VEGF use for the eye

This comment article highlights the controversy that exists in the choice for anti-VEGF drugs used for treatment of macular oedema and wet age-related macular degeneration (AMD). Two existing licensed drugs for macular oedema are ranibizumab (Lucentis) and aflibercept (Eylea). A...